Newsletter

Subscribe and recieve updates on this company.

Text STOCKS to 72727 for mobile alerts

We are excited to present OptimizeRx Corp. (OTC: OPRX).

Full DD Report for OPRX

You must become a subscriber to view this report.


Recent News from (OTC: OPRX)

OptimizeRx to Participate at Lake Street Capital Markets Best Ideas Growth Conference on September 13, 2018
ROCHESTER, Mich., Aug. 29, 2018 (GLOBE NEWSWIRE) -- OptimizeRx Corp. (OTCQB: OPRX), a leading global provider of digital health messaging for the pharmaceutical industry, has been invited to participate at the Lake Street Capital Market’s 2018 Best Ideas Growth (BIG) Conference bei...
Source: GlobeNewswire
Date: August, 29 2018 08:31
OptimizeRx Corp. (OPRX) CEO William Febbo on Q2 2018 Results - Earnings Call Transcript
OptimizeRx Corp. (OPRX) Q2 2018 Earnings Conference Call August 7, 2018, 04:30 PM ET Executives William Febbo - CEO Doug Baker - CFO Miriam Paramore - President Analysts Eric Martinuzzi - Lake Street Capital Markets Richard Baldry - ROTH Capital Andrew D'Silva - B. Rile...
Source: SeekingAlpha
Date: August, 12 2018 01:03
OptimizeRx shoots 18.3% post Q2 results
OptimizeRx ( OPRX +18.3% ) reports Q2  revenue growth of 77.7% Y/Y to $5.1M. More news on: OptimizeRx Corp., Stocks on the move, Read more ...
Source: SeekingAlpha
Date: August, 08 2018 09:59
OptimizeRx beats by $0.04, beats on revenue
OptimizeRx (NASDAQ: OPRX ): Q2 EPS of $0.02 beats by $0.04 . More news on: OptimizeRx Corp., Earnings news and commentary, Consumer stocks news, , Read more ...
Source: SeekingAlpha
Date: August, 07 2018 16:17
OptimizeRx Reports Second Quarter 2018 Results; Net Revenue Up 78% to Record $5.1 Million, Driving $0.02 EPS
ROCHESTER, Mich., Aug. 07, 2018 (GLOBE NEWSWIRE) -- OptimizeRx Corp. (OTCQB:OPRX), a leading global provider of digital health messaging for the pharmaceutical industry, reported results for the second quarter ended June 30, 2018. Quarterly comparisons are to the same year-ago quarter. ...
Source: GlobeNewswire
Date: August, 07 2018 16:00
OptimizeRx Sets Second Quarter 2018 Conference Call for Tuesday, August 7, 2018 at 4:30 p.m. ET
ROCHESTER, Mich., July 17, 2018 (GLOBE NEWSWIRE) -- OptimizeRx Corp. (NASDAQ:OPRX), a leading global provider of digital health messaging for the pharmaceutical industry, will hold a conference call on Tuesday, August 7, 2018 at 4:30 p.m. Eastern time to discuss results for the second qua...
Source: GlobeNewswire
Date: July, 17 2018 08:31
OptimizeRx Uplists to the Nasdaq Capital Market
ROCHESTER, Mich., June 19, 2018 (GLOBE NEWSWIRE) -- OptimizeRx Corp. (NASDAQ:OPRX), a leading global provider of digital health messaging for the pharmaceutical industry, has uplisted to the Nasdaq Capital Market, with its common stock to commence trading on the exchange beginning Friday,...
Source: GlobeNewswire
Date: June, 19 2018 11:45
OptimizeRx to Participate at ROTH London Conference on June 19-20, 2018
ROCHESTER, Mich. and LONDON, June 12, 2018 (GLOBE NEWSWIRE) -- OptimizeRx Corp. (OTCQB:OPRX), the nation's leading provider of digital health messaging for the pharmaceutical industry, has been invited to participate at the ROTH London Conference being held on June 19-20, 2018 at the Dorc...
Source: GlobeNewswire
Date: June, 12 2018 12:00
OptimizeRx to Present at 8th Annual LD Micro Invitational Conference on June 5, 2018
ROCHESTER, MI / ACCESSWIRE / May 21, 2018 / OptimizeRx Corp. (OTCQB: OPRX), the nation's leading provider of digital health messaging for the pharmaceutical industry, has been invited to present at 8th Annual LD Micro Invitational Conference being held on June 4-6, 2018 at the Luxe Sunset ...
Source: ACCESSWIRE
Date: May, 21 2018 08:31
OptimizeRx to Participate at B. Riley FBR's 19th Annual Institutional Investor Conference on May 23-24, 2018
ROCHESTER, Mich., May 09, 2018 (GLOBE NEWSWIRE) -- OptimizeRx Corp. (OTCQB:OPRX), the nation’s leading provider of digital health messaging for the pharmaceutical industry, has been invited to participate at B. Riley FBR’s 19th Annual Institutional Investor Conference being ...
Source: GlobeNewswire
Date: May, 09 2018 08:31

 


Last 5 Days Trading Activity

DateOpen PriceClose PriceHighLowVolume
2018-12-1014.8114.9015.5813.5226,111
2018-12-0714.7515.0016.0114.7534,292
2018-12-0615.9015.0016.2215.0020,162
2018-12-0515.4416.1116.34515.4417,861
2018-12-0415.4416.1116.34515.4417,861

Last 5 Days Short Activity

DateShort VolumeTotal VolumeShort PercentageShort Indicator
2018-06-212,85611,66224.4898Cover
2018-06-205,64632,21717.5249Cover
2018-06-1929,80085,70834.7692Cover
2018-06-18170,236188,65090.2391Short
2018-06-1514,00124,18657.8889Short

* Cover Mode

Short Analysis provided by Squeeze Report. Get a complete short report on OPRX.


About OptimizeRx Corp. (OTC: OPRX)

Logo for OptimizeRx Corp. (OTC: OPRX)

Based in Rochester, Michigan, OptimizeRx Corporation OTCQB:OPRX is a health technology software company that is revolutionizing the point of care experience through technology to improve clinical decisions and outcomes. OptimizeRx s unique consumer and physician platforms help patients better afford and comply with their medicines and healthcare products, while offering pharmaceutical and healthcare companies effective ways to expand awareness, access and adherence to their medications. OptimizeRx core product replaces drug samples with electronic trial vouchers and copay coupon savings that are electronically added to an e Prescription and sent electronically to the pharmacy and is integrated within leading electronic health record EHR platforms in the country, including Allscripts, DrFirst, NewCrop, Quest Diagnostics, Practice Fusion and other EHRs to reach over , healthcare providers. In turn, OptimizeRx promotes patient savings and support from the world s largest pharmaceutical companies, including Pfizer, Merck, Lilly, Novartis, AstraZeneca and many others. For more information, visit www.optimizerx.com.

 

Contact Information

 

 

Current Management

  • William J. Febbo / CEO
  • Miriam J Paramore / President
  • Doug Baker / CFO
  • Ed Berger / Senior VP
  • Terry Hamilton / Senior VP
  • William J. Febbo /
  • Gus Halas /
  • James Lang /
  • Jack T Pinney, MD /
  • Lynn O Connor Vos /

Current Share Structure

  • Market Cap: $43,977,122 - 03/16/2018
  • Authorized: 500,000,000 - 03/01/2018
  • Issue and Outstanding: 29,318,081 - 03/01/2018
  • Float: 20,522,656 - 03/01/2018

 


Recent Filings from (OTC: OPRX)

Report of unscheduled material events or corporate changes.
Filing Type: 8-KFiling Source: edgar
Filing Date: May, 16 2018
Statement of beneficial ownership of common stock by certain persons
Filing Type: SC 13GFiling Source: edgar
Filing Date: May, 14 2018
Official notice of an offering of securities that is made without registration under the Securities Act in reliance on an exemption provided by Regulation D and Section 4(6) under the Act
Filing Type: DFiling Source: edgar
Filing Date: May, 11 2018
Amendment to a SC 13D filing
Filing Type: SC 13D/AFiling Source: edgar
Filing Date: May, 10 2018
Report of unscheduled material events or corporate changes.
Filing Type: 8-KFiling Source: edgar
Filing Date: May, 09 2018
Report of unscheduled material events or corporate changes.
Filing Type: 8-KFiling Source: edgar
Filing Date: May, 08 2018
Report of unscheduled material events or corporate changes.
Filing Type: 8-KFiling Source: edgar
Filing Date: May, 04 2018
Report of unscheduled material events or corporate changes.
Filing Type: 8-KFiling Source: edgar
Filing Date: May, 03 2018
Quarterly report with a continuing view of a company's financial position
Filing Type: 10-QFiling Source: edgar
Filing Date: May, 02 2018
Report of unscheduled material events or corporate changes.
Filing Type: 8-KFiling Source: edgar
Filing Date: April, 25 2018

 

 


Daily Technical Chart for (OTC: OPRX)

Daily Technical Chart for (OTC: OPRX)


Stay tuned for daily updates and more on (OTC: OPRX)

It most certainly could but even more important is the recent overwhelming interest in the company. Check out Investors Hub and search on Twitter

More to come on (OTC: OPRX)

Do your DD and if you choose, be ready to go!


 

The Research: All source information contained in this email is from the public sources mentioned below.

 

 
 

Thank you

DD Report
@DDReports

 

 


Disclaimer: DD Report publishes reports providing information on selected companies. DD Report is not a registered investment advisor or broker-dealer. This report is provided as an information service only, and the statements and opinions in this report should not be construed as an offer or solicitation to buy or sell any security. DD Report accepts no liability for any loss arising from an investors reliance on or use of this report. An investment in OPRX is considered to be highly speculative and should not be considered unless a person can afford a complete loss of investment. DD Report has received no compensation for the publication and circulation of this report. DD Report does not own any shares of OPRX and does not buy, sell, or trade any shares of OPRX. This report contains forward-looking statements, which involve risks, and uncertainties that may cause actual results to differ materially from those set forth in the forward-looking statements. Copyright 2018 by DD Report. All rights reserved. Our Full Disclaimer: https://dd.report/disclaimer/